Was the C282Y mutation an Irish Gaelic mutation that the Vikings helped disseminate?: HLA haplotype observations of hemochromatosis from the west coast of Sweden

European Journal of Haematology

Volumn 86, Issue 1, 2011, Pages 75-82

  Olsson, Karl Sigvard ^a   Konar, Jan ^b   Dufva, Inge Hoegh ^c,e   Ricksten, Anne ^c   Raha Chowdhury, Ruma ^d,f  

^a Section of Hematology and Coagulation   (Sweden)

^b Blood Transfusion Unit   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Ferritin; Genealogy; Hemochromatosis; HFE; HLA; Iron overload; Pedigrees; Recombinations

Indexed keywords

CYSTEINE; FERRITIN; HLA A3 ANTIGEN; TRANSFERRIN; TYROSINE;

ARTICLE; BONE MARROW; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC RECOMBINATION; GENETIC VARIABILITY; HAPLOTYPE; HAPLOTYPE MAP; HEMOCHROMATOSIS; HLA SYSTEM; HUMAN; IRELAND; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PEDIGREE; POPULATION GENETICS; PRIORITY JOURNAL; SWEDEN; TRANSFERRIN BLOOD LEVEL;

CASE-CONTROL STUDIES; EUROPE; FOUNDER EFFECT; GENE FREQUENCY; GENETICS, POPULATION; GENOTYPE; HAPLOTYPES; HEMOCHROMATOSIS; HISTORY, MEDIEVAL; HLA-A3 ANTIGEN; HUMANS; IRELAND; LINKAGE DISEQUILIBRIUM; MUTATION, MISSENSE; PEDIGREE; SWEDEN;

EID: 78650118368     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01536.x     Document Type: Article

References (45)

1. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
2. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004;350:2383-97.
3. O'Sullivan EP, McDermott JH, Murphy MS, Sen S, Walsh CH. Declining prevalence of diabetes mellitus in hereditary haemochromatosis - the result of earlier diagnosis. Diabetes Res Clin Pract 2008;81:316-20.
4. Simon M, Le Mignon L, Fauchet R, Yaouanq J, David V, Edan G, Bourel M. A study of 609 HLA haplotypes marking for the hemochromatosis gene. Am J Hum Genet 1987;41:89-105.
5. Distante S, Robson KJ, Graham-Campbell J, Arnaiz-Villena A, Brissot P, Worwood M. The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum Genet 2004;115:269-79.
6. Barton EH, Barton JC, Hollowell WW, Acton RT. Countries of ancestry reported by hemochromatosis probands and control subjects in central Alabama. Ethn Dis 2004;14:73-81.
7. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test 2000;4:183-98.
8. Murphy S, Curran MD, McDougall N, Callender ME, O'Brien CJ, Middleton D. High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population-implications for haemochromatosis. Tissue Antigens 1998;52:484-8.
9. Byrnes V, Ryan E, Barrett S, Kenny P, Mayne P, Crowe J. Genetic hemochromatosis, a Celtic disease: is it now time for population screening? Genet Test 2001;5:127-30.
10. Kirk L, Bird J, Ramadan S, Samad A, Adebayo G, Lourens W, Williams J. Haemochromatosis gene frequency in a control and diabetic Irish population. Ir J Med Sci 2009;178:39-42.
11. Campbell S, George DK, Robb SD, Spooner R, McDonagh TA, Dargie HJ, Mills PR. The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease. Heart 2003;89:1023-6.
12. Lucotte G, Dieterlen F. A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells Mol Dis 2003;31:262-7.
13. Whittington CA. Was the C282Y mutation an Irish Gaelic mutation that the Vikings help disseminate? Med Hypotheses 2006;67:1270-3.
14. Thorstensen K, Kvitland MA, Irgens WO, Hveem K, Asberg A. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation. Scand J Clin Lab Invest 2010;70:92-7.
15. Olsson KS, Ritter B. Idiopatisk hemokromatose. Tidsskr Nor Laegeforen 1981;29:101.
16. Milman N, Pedersen P. Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 2003;64:36-47.
17. Raha-Chowdhury R, Gruen JR. Localization, allelic heterogeneity, and origins of the hemochromatosis gene. In: Barton J, Edwards CQ, eds. Hemochromatosi. UK: Cambridge University Press, 2000:75-90.
18. Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 1976;17:332-4.
19. Olsson KS, Ritter B, Raha-Chowdhury R. HLA-A3-B14 and the origin of the hemochromatosis C282Y mutation. Founder effects and recombination events during 12 generations in a Scandinavian family with major iron overload. Eur J Haematol 2009;84:145-53.
20. Barton JC, Clayborn Barton J, Acton RT. Longer survival associated with HLA-A*03, B*14 among 212 hemochromatosis probands with HFE C282Y homozygosity and HLA-A and -B typing and haplotyping. Eur J Haematol. 2010;85:439-47.
21. Bell H, Thordal C, Raknerud N, Hansen T, Bosnes V, Halvorsen R, et al. Prevalence of hemochromatosis among first-time and repeat blood donors in Norway. J Hepatol 1997;26:272-9.
22. Milman N, Graudal N, Nielsen LS, Fenger K. An HLA study in 74 Danish haemochromatosis patients and in 21 of their families. Clin Genet 1992;41:6-12.
23. Lombard MG. Genetics of Idiopathic Haemochromatosis in an Irish population. PhD thesis. Dublin University, Dublin, 1987.
24. Hudec M, Grigerova M, Walsh CH. Secondary hypothyroidism in hereditary hemochromatosis: recovery after iron depletion. Thyroid 2008;18:255-7.
25. McEvoy B, Brady C, Moore LT, Bradley DG. The scale and nature of Viking settlement in Ireland from Y-chromosome admixture analysis. Eur J Hum Genet 2006;14:1288-94.
26. Olsson KS, Ritter B, Rosén U, Heedman PA, Staugård F. Prevalence of iron overload in central Sweden. Acta Med Scand 1983;213:145-50.
27. Vartdal F, Gaudernack G, Funderud S, Bratlie A, Lea T, Ugelstad J, Thorsby E. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation - a fast and reliable technique. Tissue Antigens 1986;28:301-12.
28. Schipper RF, D'Amaro J, Bakker JT, Bakker J, Van Rood JJ, Oudshoorn M. HLA gene haplotype frequencies in bone marrow donors worldwide registries. Hum Immunol 1997;52:54-71.
29. Olsson KS, Kristoffersson RM, Konar J. Prevalence of iron overload in blood donors in Göteborg, Sweden. Clin Lab Haematol 1995;17:372-3.
30. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M. HFE mutations, iron deficiency and overload in 10, 500 blood donors. Br J Haematol 2001;114:474-84.
31. Saugstad LF. Anthropological significance of phenylketonuria. Clin Genet 1975;7:52-61.
32. Ritter B, Säfwenberg J, Olsson KS. HLA as a marker of the hemochromatosis gene in Sweden. Hum Genet 1984;68:62-6.
33. Beckman LE, Sjöberg K, Eriksson S, Beckman L. Haemochromatosis gene mutations in Finns, Swedes and Swedish Saamis. Hum Hered 2001;52:110-2.
34. Cardoso EM, Stål P, Hagen K, Cabeda JM, Esin S, De Sousa M, Hultcrantz R. HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 1998;243:203-8.
35. Tuomainen TP, Kontula K, Nyyssönen K, Lakka TA, Heliö T, Salonen JT. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 1999;100:1274-9.
36. Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, et al. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet 2001;358:1405-9.
37. O'Donnell KA, O'Neill C, Tighe O, Bertorelle G, Naughten E, Mayne PD, Croke DT. The mutation spectrum of hyperphenylalaninaemia in the Republic of Ireland: the population history of the Irish revisited. Eur J Hum Genet 2002;10:530-8.
38. Olsson KS, Ritter B, Hansson N, Chowdhury RR. HLA haplotype map of river valley populations with hemochromatosis traced through five centuries in Central Sweden. Eur J Haematol 2008;81:36-46.
39. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-805.
40. Cruz E, Vieira J, Almeida S, Lacerda R, Gartner A, Cardoso CS, Alves H, Porto G. A study of 82 extended HLA haplotypes in HFE-C282Y homozygous hemochromatosis subjects: relationship to the genetic control of CD8+ T-lymphocyte numbers and severity of iron overload. BMC Med Genet 2006;7:16.
41. Barton JC, Wiener HW, Acton RT, Go RC. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Blood Cells Mol Dis 2005;34:38-47.
42. Flanagan JM, McMahon G, Brendan Chia SH, et al. The role of human demographic history in determining the distribution and frequency of transferase-deficient galactosaemia mutations. Heredity 2010;104:148-54.
43. McEvoy B, Richards M, Forster P, Bradley DG. The Longue Durée of genetic ancestry: multiple genetic marker systems and Celtic origins on the Atlantic facade of Europe. Am J Hum Genet 2004;75:693-702.
44. Cardoso CS, Oliveira P, Porto G, Obercanins C, Mascarenhas M, Rodrigues P, Kury F, De Sousa M. Comparative study of the two more frequent HFE mutations (C282Y and H63D): significant different allelic frequencies between the North and South of Portugal. Eur J Hum Genet 2001;9:843-8.
45. Fredell Å. A Mo(ve)ment in Time? A comparative study of a rock-picture theme in Galicia and Bohuslän. In: Fredell Åsa C, ed. Representations and Communications. Creating an Archeological Matrix of Late Prehistoric Rock Art. Oxford, UK: Kristian Kristiansen and Felipe Criado Boado, Oxbow Books, 2010:52-74.